| NDC Code | 43066-129-05 |
|---|
| Package Description | 5 CARTON in 1 CARTON (43066-129-05) / 1 SYRINGE, PLASTIC in 1 CARTON (43066-129-01) / 10 mL in 1 SYRINGE, PLASTIC |
|---|
| Product NDC | 43066-129 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Succinylcholine Chloride |
|---|
| Non-Proprietary Name | Succinylcholine Chloride |
|---|
| Dosage Form | INJECTION, SOLUTION |
|---|
| Usage | INTRAMUSCULAR; INTRAVENOUS |
|---|
| Start Marketing Date | 20240924 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA218878 |
|---|
| Manufacturer | Baxter Healthcare Corporation |
|---|
| Substance Name | SUCCINYLCHOLINE CHLORIDE DIHYDRATE |
|---|
| Strength | 20 |
|---|
| Strength Unit | mg/mL |
|---|
| Pharmacy Classes | Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE] |
|---|